Chinese supply chain industry (stock code: 03708) released its interim financial results, with a net loss of HK$1.857 million for shareholders.

19:39 25/02/2026

The Chinese supply chain industry (03708) has announced its performance for the six months ending on December 31, 2025, with revenue of HK$302 million, a decrease of 3.8% compared to the previous year. The company's owners' share of losses amounts to HK$1.857 million, compared to profits of HK$1.952 million in the same period last year. Basic loss per share is 0.03 HK cents.

China Supply Chain Industry (03708) released its six-month financial results ending December 31, 2025, with revenue of 302 million Hong Kong dollars, a decrease of 3.8% year-on-year. The company's attributable loss amounted to 1.857 million Hong Kong dollars, compared to a profit of 1.952 million Hong Kong dollars in the same period last year. Basic loss per share was 0.03 Hong Kong cents. The decrease in revenue during this period was mainly due to a decrease in income from the building maintenance division. The group incurred a loss in this period mainly due to an increase in administrative expenses.

JIUYUAN GENE (02566): JiKeQin's listing application has been accepted by the National Medical Products Administration.

Novo Nordisk A/S Sponsored ADR Class B (NVO.US) invests up to $2.1 billion in partnership with Vivtex, doubling down on the next generation of oral weight loss drugs.

Culturecom Holdings Limited (00343): Chen Shuwen resigns as an independent non-executive director.

JIUYUAN GENE (02566): JiKeQin's listing application has been accepted by the National Medical Products Administration.

Novo Nordisk A/S Sponsored ADR Class B (NVO.US) invests up to $2.1 billion in partnership with Vivtex, doubling down on the next generation of oral weight loss drugs.

Culturecom Holdings Limited (00343): Chen Shuwen resigns as an independent non-executive director.